{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:40:19Z","timestamp":1790977219721,"version":"4.1.0"},"reference-count":96,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Diabetes Mellitus (DM) is a significant global concern. Many diabetic patients will experience complications due to angiopathy, neuropathy, and immune dysfunction, namely diabetic foot ulcers (DFU) and diabetic foot infections (DFI), which can result in lower limb amputation and potentially death. The prevalence of common superficial fungal infections, such as tinea pedis and onychomycosis, can directly increase a diabetic patient\u2019s risk of developing both DFU and DFI. In this review article, we discuss the etiology of diabetic foot complications as well as considerations for both screening and management. We also discuss the role of the dermatologist within a multidisciplinary care team in prescribing and managing treatments for tinea pedis and onychomycosis infections within this patient population. We believe that reducing the burden of these fungal infections in the context of the diabetic foot will help reduce DFU and DFI complications and their associated morbidity and mortality.<\/jats:p>","DOI":"10.3390\/jof10080577","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T03:49:36Z","timestamp":1723693776000},"page":"577","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diabetic Foot and Fungal Infections: Etiology and Management from a Dermatologic Perspective"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada"},{"name":"Mediprobe Research Inc., London, ON N5X 2P1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avner","family":"Shemer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Economopoulos","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc., London, ON N5X 2P1, Canada"},{"name":"Department of Medical Biophysics, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 3K7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesbah","family":"Talukder","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc., London, ON N5X 2P1, Canada"},{"name":"School of Pharmacy, BRAC University, Dhaka 1212, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2021). IDF Diabetes Atlas, International Diabetes Federation."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2023.10578","article-title":"Diabetic Foot Ulcers: A Review","volume":"330","author":"Armstrong","year":"2023","journal-title":"JAMA"},{"key":"ref_3","unstructured":"(2024, June 12). Centers for Disease Control National Diabetes Statistics Report, Available online: https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s00125-006-0431-0","article-title":"Predictors, Consequences and Costs of Diabetes-Related Lower Extremity Amputation Complicating Type 2 Diabetes: The Fremantle Diabetes Study","volume":"49","author":"Davis","year":"2006","journal-title":"Diabetologia"},{"key":"ref_5","unstructured":"Cowie, C.C., Casagrande, S.S., and Geiss, L.S. (2018). Prevalence and Incidence of Type 2 Diabetes and Prediabetes. Diabetes in America, National Institute of Diabetes and Digestive and Kidney Diseases (US). [3rd ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.semvascsurg.2021.02.006","article-title":"Diabetic Foot Ulcers: Epidemiology and the Role of Multidisciplinary Care Teams","volume":"34","author":"Sorber","year":"2021","journal-title":"Semin. Vasc. Surg."},{"key":"ref_8","unstructured":"Casagrande, S.S., and Cowie, C.C. (2018). Health Insurance and Diabetes. Diabetes in America, National Institute of Diabetes and Digestive and Kidney Diseases (US). [3rd ed.]."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.semvascsurg.2022.11.001","article-title":"Multidisciplinary Approach to Decreasing Major Amputation, Improving Outcomes, and Mitigating Disparities in Diabetic Foot and Vascular Disease","volume":"36","author":"McDermott","year":"2023","journal-title":"Semin. Vasc. Surg."},{"key":"ref_10","unstructured":"Boyko, E.J., Monteiro-Soares, M., and Wheeler, S.G.B. (2018). Peripheral Arterial Disease, Foot Ulcers, Lower Extremity Amputations, and Diabetes. Diabetes in America, National Institute of Diabetes and Digestive and Kidney Diseases (US). [3rd ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Costa, D., Ielapi, N., Caprino, F., Giannotta, N., Sisinni, A., Abramo, A., Ssempijja, L., Andreucci, M., Bracale, U.M., and Serra, R. (2022). Social Aspects of Diabetic Foot: A Scoping Review. Soc. Sci., 11.","DOI":"10.3390\/socsci11040149"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/ANS.0000000000000328","article-title":"I Cannot Afford Off-Loading Boots: Perceptions of Socioeconomic Factors Influencing Engagement in Self-Management of Diabetic Foot Ulcer","volume":"43","author":"Costa","year":"2020","journal-title":"Adv. Nurs. Sci."},{"key":"ref_13","unstructured":"Pop-Busui, R., Boulton, A.J.M., and Sosenko, J.M. (2018). Peripheral and Autonomic Neuropathy in Diabetes. Diabetes in America, National Institute of Diabetes and Digestive and Kidney Diseases (US). [3rd ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1067\/mjd.2000.110376","article-title":"Onychomycosis and Tinea Pedis in Patients with Diabetes","volume":"43","author":"Rich","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/wrr.13108","article-title":"Cutaneous Changes in Diabetic Patients: Primed for Aberrant Healing?","volume":"31","author":"Chen","year":"2023","journal-title":"Wound Repair. Regen."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.jfas.2016.01.012","article-title":"Mortality After Nontraumatic Major Amputation Among Patients With Diabetes and Peripheral Vascular Disease: A Systematic Review","volume":"55","author":"Thorud","year":"2016","journal-title":"J. Foot Ankle Surg."},{"key":"ref_17","first-page":"26","article-title":"Diabetic Foot Infections: A Comprehensive Overview","volume":"23","author":"Pitocco","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Burgess, J.L., Wyant, W.A., Abujamra, B.A., Kirsner, R.S., and Jozic, I. (2021). Diabetic Wound-Healing Science. Medicina, 57.","DOI":"10.3390\/medicina57101072"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.semvascsurg.2019.02.001","article-title":"The Diabetic Foot: Pathophysiology, Evaluation, and Treatment","volume":"31","author":"Bandyk","year":"2018","journal-title":"Semin. Vasc. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.dsx.2016.06.023","article-title":"Understanding Diabetic Foot Infection and Its Management","volume":"11","author":"Noor","year":"2017","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_21","unstructured":"Ahmad, S.I. (2012). CHAPTER 12 DIABETIC FOOT: A Continuing Challenge. Diabetes: An Old Disease, a New Insight, Landes Bioscience and Springer Science + Business Media, LLC."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Viigimaa","year":"2019","journal-title":"Curr. Vasc. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","article-title":"Epidemiology of Diabetes Mellitus and Cardiovascular Disease","volume":"21","author":"Glovaci","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, Cardiovascular Disease and the Microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semvascsurg.2012.04.005","article-title":"Diabetic Vascular Disease: Characteristics of Vascular Disease Unique to the Diabetic Patient","volume":"25","author":"Gibbons","year":"2012","journal-title":"Semin. Vasc. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of Diabetic Complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2337\/diacare.27.12.2843","article-title":"Peripheral Arterial Disease, Diabetes, and Mortality","volume":"27","author":"Leibson","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-8587(24)00110-4","article-title":"Causes, Prevention, and Management of Diabetes-Related Foot Ulcers","volume":"12","author":"Jeffcoate","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and Microvascular Endothelial Dysfunction in Diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J. Diabetes"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2217\/fca-2018-0045","article-title":"Type-2 Diabetes Mellitus and Cardiovascular Disease","volume":"14","author":"Henning","year":"2018","journal-title":"Future Cardiol."},{"key":"ref_32","first-page":"e53279","article-title":"Navigating the Frontier: Emerging Techniques for Detecting Microvascular Complications in Type 2 Diabetes Mellitus: A Comprehensive Review","volume":"16","author":"Raut","year":"2024","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic Autonomic Neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic Neuropathy: Clinical Manifestations and Current Treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Papachristou, S., Pafili, K., and Papanas, N. (2021). Skin AGEs and Diabetic Neuropathy. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00697-7"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2005-871325","article-title":"Diabetic Neuropathy","volume":"25","author":"Kelkar","year":"2005","journal-title":"Semin. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jdi.12833","article-title":"Diabetic Neuropathy and the Sensory Neuron: New Aspects of Pathogenesis and Their Treatment Implications","volume":"9","author":"Kobayashi","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bowling, F.L., Foley, K.J., and Boulton, A.J.M. (2022). Diabetic Foot. Diabetic Neuropathy, Elsevier.","DOI":"10.1016\/B978-0-12-820669-0.00022-0"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Muramatsu, K. (2020). Diabetes Mellitus-Related Dysfunction of the Motor System. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207485"},{"key":"ref_40","first-page":"1211","article-title":"Diabetic Skin Changes Can Benefit from Moisturizer and Cleanser Use: A Review","volume":"18","author":"Kirsner","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Miyashita, A., Kobayashi, M., Yokota, T., and Zochodne, D.W. (2023). Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065977"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/dmrr.2257","article-title":"Motor Dysfunction in Diabetes","volume":"28","author":"Andersen","year":"2012","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11892-014-0541-x","article-title":"Microvascular Dysfunction in the Context of Diabetic Neuropathy","volume":"14","author":"Stirban","year":"2014","journal-title":"Curr. Diab Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.CON.0000411568.34085.3e","article-title":"Diabetic Neuropathy","volume":"18","author":"Smith","year":"2012","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_46","first-page":"442","article-title":"Type 2 Diabetes and Its Impact on the Immune System","volume":"16","author":"Berbudi","year":"2019","journal-title":"Curr. Diabetes Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in Obesity, Diabetes, and Related Disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Daryabor, G., Atashzar, M.R., Kabelitz, D., Meri, S., and Kalantar, K. (2020). The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01582"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1159\/000479904","article-title":"Insulin Influences LPS-Induced TNF-\u03b1 and IL-6 Release Through Distinct Pathways in Mouse Macrophages from Different Compartments","volume":"42","author":"Tessaro","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2310\/6670.2007.00056","article-title":"Chemokines and Diabetic Wound Healing","volume":"15","author":"Ochoa","year":"2007","journal-title":"Vascular"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-013-1751-2","article-title":"Skin and Diabetes Mellitus: What Do We Know?","volume":"355","author":"Quondamatteo","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002512-200421020-00003","article-title":"Common Fungal Infections of the Feet in Patients with Diabetes Mellitus","volume":"21","author":"Tan","year":"2004","journal-title":"Drugs Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00128071-200910040-00001","article-title":"Toenail Onychomycosis in Diabetic Patients: Issues and Management","volume":"10","author":"Mayser","year":"2009","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and Epidemiology of Toenail Onychomycosis in Diabetic Subjects: A Multicentre Survey","volume":"139","author":"Gupta","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2340\/00015555-0113","article-title":"Prevalence of Toe Nail Onychomycosis in Diabetic Patients","volume":"86","author":"Saunte","year":"2006","journal-title":"Acta Derm. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11046-008-9112-5","article-title":"Onychomycosis Incidence in Type 2 Diabetes Mellitus Patients","volume":"166","year":"2008","journal-title":"Mycopathologia"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-4632.2008.03606.x","article-title":"Metabolic Syndrome Associated with Toenail Onychomycosis in Taiwanese with Diabetes Mellitus","volume":"47","author":"Chang","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1757-1146-4-26","article-title":"Safety and Efficacy of Tinea Pedis and Onychomycosis Treatment in People with Diabetes: A Systematic Review","volume":"4","author":"Matricciani","year":"2011","journal-title":"J. Foot Ankle Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/15347346211009409","article-title":"Onychomycosis and Tinea Pedis in the Feet of Patients With Diabetes","volume":"22","year":"2023","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1742-4801.2005.00097.x","article-title":"Can the Use of a Topical Antifungal Nail Lacquer Reduce Risk for Diabetic Foot Ulceration? Results from a Randomised Controlled Pilot Study","volume":"2","author":"Armstrong","year":"2005","journal-title":"Int. Wound J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e076441","DOI":"10.1136\/bmjopen-2023-076441","article-title":"Association between Onychomycosis and Ulcerative Complications in Patients with Diabetes: A Longitudinal Cohort Study in Dutch General Practice","volume":"14","author":"Watjer","year":"2024","journal-title":"BMJ Open."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1464-5491.2009.02722.x","article-title":"Fungal Foot Infection, Cellulitis and Diabetes: A Review","volume":"26","author":"Bristow","year":"2009","journal-title":"Diabet. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1002\/dmrr.818","article-title":"Non-Ulcerative Skin Pathologies of the Diabetic Foot","volume":"24","author":"Bristow","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in Patients with Diabetes Mellitus: A Review of Pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e3657","DOI":"10.1002\/dmrr.3657","article-title":"Practical Guidelines on the Prevention and Management of Diabetes-Related Foot Disease (IWGDF 2023 Update)","volume":"40","author":"Schaper","year":"2024","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2010.428","article-title":"Does This Patient with Diabetes Have Large-Fiber Peripheral Neuropathy?","volume":"303","author":"Jamil","year":"2010","journal-title":"JAMA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2021.2126","article-title":"Lower Extremity Peripheral Artery Disease without Chronic Limb-Threatening Ischemia: A Review","volume":"325","author":"Polonsky","year":"2021","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejvs.2023.07.020","article-title":"Editor\u2019s Choice\u2014The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer","volume":"66","author":"Fitridge","year":"2023","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk Stratification Based on Wound, Ischemia, and Foot Infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejvs.2019.03.040","article-title":"Editor\u2019s Choice\u2014The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis","volume":"58","author":"Ponchant","year":"2019","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciad255","article-title":"Evaluation and Management of Diabetes-Related Foot Infections","volume":"77","author":"Armstrong","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2337\/dc07-2367","article-title":"Use of the SINBAD Classification System and Score in Comparing Outcome of Foot Ulcer Management on Three Continents","volume":"31","author":"Ince","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lin, C.W., Yang, H.M., Hung, S.Y., Chen, I.W., and Huang, Y.Y. (2021). The Analysis for Time of Referral to a Medical Center among Patients with Diabetic Foot Infection. BMC Fam. Pract., 22.","DOI":"10.1186\/s12875-020-01363-y"},{"key":"ref_74","unstructured":"(2024, July 02). NHS Digital NDFA Interval Review: July 2014\u2013March 2021. Available online: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-footcare-audit\/2014-2021#."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mpmed.2014.10.006","article-title":"The Diabetic Foot","volume":"43","author":"Boulton","year":"2015","journal-title":"Medicine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2015.10.003","article-title":"The Management of Diabetic Foot: A Clinical Practice Guideline by the Society for Vascular Surgery in Collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine","volume":"63","author":"Hingorani","year":"2016","journal-title":"J. Vasc. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/wound.2017.0743","article-title":"Publicly Reported Wound Healing Rates: The Fantasy and the Reality","volume":"7","author":"Fife","year":"2018","journal-title":"Adv. Wound Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13047-020-0369-3","article-title":"Ulcer Metastasis? Anatomical Locations of Recurrence for Patients in Diabetic Foot Remission","volume":"13","author":"Petersen","year":"2020","journal-title":"J. Foot Ankle Res."},{"key":"ref_79","unstructured":"Embil, J.M.A., and Trepman, E. (2024). Diabetic Foot Infections. CPS Therapeutic Choices, Canadian Pharmacists Association."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.det.2006.03.009","article-title":"Onychomycosis Therapies: Strategies to Improve Efficacy","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatol. Clin."},{"key":"ref_81","first-page":"24","article-title":"Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics","volume":"17","author":"Yousefian","year":"2024","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7547\/13-110.1","article-title":"Therapies for Onychomycosis: A Systematic Review and Network Meta-Analysis of Mycological Cure","volume":"105","author":"Gupta","year":"2015","journal-title":"J. Am. Podiatr. Med. Assoc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40257-021-00660-1","article-title":"Efinaconazole in Onychomycosis","volume":"23","author":"Gupta","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_84","unstructured":"Novartis Pharmaceuticals Canada Inc. (2023). Product Monograph LAMISIL (Terbinafine), Novartis Pharmaceuticals Canada Inc."},{"key":"ref_85","unstructured":"Mint Pharmaceuticals Inc. (2018). Product Monograph MINT-ITRACONAZOLE (Itraconazole), Mint Pharmaceuticals Inc."},{"key":"ref_86","unstructured":"Bausch Health, Canada Inc. (2020). PRODUCT MONOGRAPH\u2014JUBLIA\u00ae Efinaconazole, Topical Solution, 10% w\/w Topical Antifungal Agent, Bausch Health, Canada Inc."},{"key":"ref_87","unstructured":"Valeant Canada LP (2012). Product Monograph\u2014Penlac (Ciclopirox Topical Solution, 8% w\/w) Nail Lacquer, Topical Antifungal Agent, Valeant Canada LP."},{"key":"ref_88","unstructured":"Anacor Pharmaceuticals Inc. (2014). Highlights of Prescribing Information\u2014KERYDIN (Tavaborole) Topical Solution, 5%, Anacor Pharmaceuticals Inc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/14787210.2024.2362911","article-title":"Safety and Efficacy of New Generation Azole Antifungals in the Management of Recalcitrant Superficial Fungal Infections and Onychomycosis","volume":"22","author":"Gupta","year":"2024","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_90","unstructured":"Pfizer Canada Inc. (2018). Product Monograph DIFLUCAN (Fluconazole), Pfizer Canada Inc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1468-3083.2006.01698.x","article-title":"Pulse Itraconazole vs. Continuous Terbinafine for the Treatment of Dermatophyte Toenail Onychomycosis in Patients with Diabetes Mellitus","volume":"20","author":"Gupta","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/13543784.2016.1142529","article-title":"Novel Investigational Therapies for Onychomycosis: An Update","volume":"25","author":"Gupta","year":"2016","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail Onychomycosis: Current and Future Treatment Options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.0933-7407.2003.00933.x","article-title":"High Prevalence of Foot Diseases in Europe: Results of the Achilles Project","volume":"46","author":"Burzykowski","year":"2003","journal-title":"Mycoses"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diacare.21.4.506","article-title":"The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications","volume":"21","author":"Yosipovitch","year":"1998","journal-title":"Diabetes Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/dc05-2031","article-title":"Prediction of Diabetic Foot Ulcer Occurrence Using Commonly Available Clinical Information: The Seattle Diabetic Foot Study","volume":"29","author":"Boyko","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/8\/577\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:55Z","timestamp":1760110615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/8\/577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":96,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jof10080577"],"URL":"https:\/\/doi.org\/10.3390\/jof10080577","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}